Aston Martin Aramco Formula One® Team Now Fully Powered by NetApp Storage
8.10.2025 14:00:00 CEST | Business Wire | Press release
NetApp StorageGRID fuels AI-powered design, simulation, and race-day strategy for competitive motorsport team
The Aston Martin Aramco Formula One® Team today announced that it has completed its migration to run 100 percent of its data storage on NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company. Aston Martin Aramco relies on NetApp’s unified, secure and AI-ready data infrastructure to power its design, simulation, and trackside operations.
Building an Intelligent Data Infrastructure powered entirely by NetApp solutions enables the Aston Martin Aramco team to benefit from seamless access to critical data, empowering faster decision-making measured in milliseconds. This includes the integration of AI-driven workflows, enabling faster design-to-build cycles and improved performance. NetApp StorageGRID provides scalable, geo-distributed object storage with enterprise-grade resilience to handle the massive datasets generated by the Aston Martin Aramco team’s operations while BlueXP delivers unified control and observability across the entire data ecosystem.
NetApp provides high-performance data storage and real-time data management solutions that help Aston Martin Aramco analyze telemetry, optimize race strategies, and improve car performance on and off the track. By enabling seamless data access across cloud and edge environments, NetApp ensures that engineering teams can make split-second decisions based on accurate and up-to-date insights.
NetApp enables Aston Martin Aramco to run complex simulations faster and more efficiently by providing high-throughput data storage and seamless access to massive datasets across hybrid cloud environments. This accelerates design iterations, allowing engineers to refine aerodynamics, strategy, and performance before the car even hits the track.
Fabrizio Pilotti, CIO, Aston Martin Aramco Formula One™ Team: “From simulations in the CoreWeave Wind Tunnel and CFD workloads to trackside telemetry, we generate and analyze petabytes of data in the pursuit of building a winning car and a winning team. NetApp provides scalable and secure infrastructure tailored for AI capability and other high-performance computing workloads, which gives us the power we need to make the right data-driven decisions across design, simulation and race-day strategy.”
Gabie Boko, Chief Marketing Officer at NetApp: “Formula One™ is one of the most demanding technical environments in the world. Races are won by split-second determinations on the track, built on a foundation of thousands of design and engineering decisions over the preceding weeks. The Aston Martin Aramco team needs prompt access to massive datasets from multiple sources without wasting time or resources on orchestrating data across different platforms. The trust that Aston Martin Aramco has placed in NetApp as its sole storage provider is a validation of our expertise in supporting intelligent data infrastructure that enables data-driven decision-making at scale.”
Additional Resources
About NetApp
NetApp is the intelligent data infrastructure company, combining unified data storage, integrated data, operational and workload services to turn a world of disruption into opportunity for every customer. NetApp creates silo-free infrastructure, harnessing observability and AI to enable the industry’s best data management. As the only enterprise-grade storage service natively embedded in the world’s biggest clouds, our data storage delivers seamless flexibility. In addition, our data services create a data advantage through superior cyber resilience, governance, and application agility. Our operational and workload services provide continuous optimization of performance and efficiency for infrastructure and workloads through observability and AI. No matter the data type, workload, or environment, with NetApp you can transform your data infrastructure to realize your business possibilities. Learn more at www.netapp.com or follow us on X, LinkedIn, Facebook, and Instagram.
NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc. Other company and product names may be trademarks of their respective owners.
About Aston Martin Aramco Formula One™ Team
With history dating back to 1913 and its founders Lionel Martin and Robert Bamford, Aston Martin has a storied history rooted in racing. Early success at the Aston Hill Climb inspired a legacy of crafting high-performance luxury vehicles, which today includes the DB12, Vantage, Vanquish, DBX707, and the F1-inspired Aston Martin Valkyrie. The brand debuted in Grand Prix racing in 1922, claimed outright victory at Le Mans in 1959 and returned to Formula One in 2021 under Lawrence Stroll’s leadership.
The team has since made significant investments, notably opening the AMR Technology Campus in Silverstone in 2023, featuring sustainable design and a cutting-edge wind tunnel that became operational in 2025.
On-track, the driver line-up features the experienced Canadian Lance Stroll and double World Champion Fernando Alonso, supported by Test and Reserve Drivers Felipe Drugovich and Stoffel Vandoorne, along with Team Ambassador Pedro de la Rosa and Young Development Driver Jak Crawford. Aston Martin Aramco also races in the all-female F1® Academy series, with Swiss driver Tina Hausmann competing under the mentorship of the team’s F1® Academy Head of Racing and Driver Ambassador, Jessica Hawkins.
Off-track, Aston Martin Aramco continues to drive progress through its I / AM fan engagement platform, and Make A Mark ESG programme, driving sustainability, inclusion and community engagement. Partnerships with Racing Pride, Spinal Track, and the Aleto Foundation support inclusivity, accessibility, and leadership development. The team’s commitment to energy efficiency is certified by ISO 50001 compliance.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251008251429/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom